ArticleOncology research2026

Autocrine Motility Factor-Derived Tetradecapeptides as Dual-Action Chemosensitizers: Bridging Cell Competition Mechanisms with Clinical MDR Reversal in Hematological Malignancies.

Changyul Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.